Vai al contenuto

Interazioni tra farmaci

Deferasirox + Metformin-repaglinide

Gravità: Maggiore

Deferasirox and Metformin-repaglinide: major interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Deferasirox inhibits CYP2C8 and can substantially raise repaglinide exposure, which increases the risk of hypoglycemia. Repaglinide is a sensitive CYP2C8 substrate, and the combination has been studied pharmacokinetically.

Cosa significa questa interazione in parole semplici

Deferasirox and Metformin-repaglinide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Deferasirox belongs to Miscellaneous; Metformin-repaglinide belongs to Endocrine.

Livello di evidenza: High

Perché avviene

Inhibition of CYP2C8 (and to a lesser extent CYP3A4) metabolism of repaglinide.

Cosa fare

Avoid the combination if possible; otherwise reduce the repaglinide dose and monitor blood glucose closely.

Cosa chiedere al farmacista

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Deferasirox e Metformin-repaglinide, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Deferasirox with Metformin-repaglinide?

MediHelp rates the interaction as major. Deferasirox and Metformin-repaglinide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Deferasirox inhibits CYP2C8 and can substantially raise repaglinide exposure, which increases the risk of hypoglycemia. Repaglinide is a sensitive CYP2C8 substrate, and the combination has been studied pharmacokinetically.

How serious is the interaction between Deferasirox and Metformin-repaglinide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible; otherwise reduce the repaglinide dose and monitor blood glucose closely.

What other medicines interact with Metformin-repaglinide?

MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi